Evidence-Based Approach to Cholangiocarcinoma: A Systematic Review of the Current Literature

Journal of the American College of Surgeons

Volumn 208, Issue 1, 2009, Pages 134-147

  Aljiffry, Murad ^a   Abdulelah, Alhawsawi ^a   Walsh, Mark ^a   Peltekian, Kevork ^a   Alwayn, Ian ^a   Molinari, Michele ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASM STAGING; SURVIVAL ANALYSIS;

EID: 57749170768     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2008.09.007     Document Type: Review

References (192)

1. Shaib Y.H., and El-Serag H.B. The epidemiology of cholangiocarcinoma. Semin Liver Dis 24 (2004) 115-125
2. Cook D.J., Mulrow C.D., and Haynes R.B. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 126 (1997) 376-380
3. In: Mulrow C.D., and Oxman A.D. (Eds). Cochrane Collaboration Handbook (1997), Cochrane Library, Update Software, Oxford, England
4. Downs S.H., and Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomized studies of health care interventions. J Epidemiol Community Health 52 (1998) 377-384
5. Lazaridis K.N., and Gores G.J. Cholangiocarcinoma. Gastroenterology 128 (2005) 1655-1667
6. Vauthey J.N., and Blumgart L.H. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 14 (1994) 109-114
7. Shaib Y.H., Davila J.A., McGlynn K., and El-Serag H.B. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?. J Hepatol 40 (2004) 472-477
8. Shaib Y.H., El-Serag H.B., Davila J.A., et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128 (2005) 620-626
9. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33 (2001) 1353-1357
10. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 38 (1965) 241-256
11. Bismuth H., and Corlette M.B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140 (1975) 170-176
12. Carriaga M.T., and Henson D.E. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 75 (1995) 171-190
13. Broome U., Olsson R., Loof L., et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38 (1996) 610-615
14. Bergquist A., and Broome U. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 15 (2001) 643-656
15. Bergquist A., Ekbom A., Olsson R., et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 36 (2002) 321-327
16. Farrant J.M., Hayllar K.M., Wilkinson M.L., et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100 (1991) 1707-1710
17. Watanapa P., and Watanapa W.B. Liver fluke-associated cholangiocarcinoma. Br J Surg 89 (2002) 962-970
18. Haswell-Elkins M.R., Mairiang E., Mairiang P., et al. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer 59 (1994) 505-509
19. Su C.H., Shyr Y.M., Lui W.Y., and P'Eng F.K. Hepatolithiasis associated with cholangiocarcinoma. Br J Surg 84 (1997) 959-973
20. Chen M.F., Jan Y.Y., Wang C.S., et al. A reappraisal of cholangiocarcinoma in patient with hepatolithiasis. Cancer 71 (1993) 2461-2465
21. Kubo S., Kinoshita H., Hirohashi K., and Hamba H. Hepatolithiasis associated with cholangiocarcinoma. World J Surg 19 (1995) 637-641
22. Lipsett P.A., Pitt H.A., Colombani P.M., et al. Choledochal cyst disease: a changing pattern of presentation. Ann Surg 220 (1994) 644-652
23. Ohtsuka T., Inoue K., Ohuchida J., et al. Carcinoma arising in choledochocele. Endoscopy 33 (2001) 614-619
24. Goto N., Yasuda I., Uematsu T., et al. Intrahepatic cholangiocarcinoma arising 10 years after the excision of congenital extrahepatic biliary dilation. J Gastroenterol 36 (2001) 856-862
25. Sorensen H.T., Friis S., Olsen J.H., et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 28 (1998) 921-925
26. Donato F., Gelatti U., Tagger A., et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 12 (2001) 959-964
27. Kobayashi M., Ikeda K., Saitoh S., et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 88 (2000) 2471-2477
28. Sahani D., Prasad S.R., Tannabe K.K., et al. Thorotrast-induced cholangiocarcinoma: case report. Abdom Imaging 28 (2003) 72-74
29. Rubel L.R., and Ishak K.G. Thorotrast-associated cholangiocarcinoma: an epidemiologic and clinicopathologic study. Cancer 50 (1982) 1408-1415
30. Szendroi M., Memeth L., and Vajta G. Asbestos bodies in a bile duct cancer after occupational exposure. Environ Res 30 (1983) 270-277
31. Wong O., Whorton M., Foliart D., and Ragland D. An industry-wide epidemiologic study of vinyl chloride workers, 1942-1982. Am J Ind Med 20 (1991) 317-334
32. Mitacek E.J., Brunnemann K.D., Hoffmann D., et al. Volatile nitrosamines and tobacco-specific nitrosamines in the smoke of Thai cigarettes: a risk factor for lung cancer and a suspected risk factor for liver cancer in Thailand. Carcinogenesis 20 (1999) 133-137
33. Lowenfelds A.B., and Norman J. Isoniazid and bile duct cancer. JAMA 240 (1978) 434-435
34. Yen S., Hsieh C.C., and Macmahon B. Extrahepatic bile duct cancer and smoking, beverage consumption, past medical history, and oral-contraceptive use. Cancer 59 (1987) 2112-2116
35. Bergquist A., Glaumann H., Persson B., and Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 27 (1998) 311-316
36. Oh S.W., Yoon Y.S., and Shin S.A. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 23 (2005) 4742-4754
37. Malhi H., and Gores G.J. Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther 23 (2006) 1287-1296
38. Hakamada K., Sasaki M., Endoh M., et al. Late development of bile duct cancer after sphincteroplasty: a ten- to twenty-two-year follow-up study. Surgery 121 (1997) 488-492
39. DeOliveira M.L., Cunningham S.C., Cameron J.L., et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245 (2007) 755-762
40. Nakeeb A., Pitt H.A., Sohn T.A., et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224 (1996) 463-473
41. Khan S.A., Thomas H.C., Davidson B.R., and Taylor-Robinson S.D. Cholangiocarcinoma. Lancet 366 (2005) 1303-1314
42. Khan S.A., Davidson B.R., Goldin R., et al. Guidelines for the diagnosis and management of cholangiocarcinoma. Gut 51 (2002) S6 I1-I9
43. Jarnagin W.R. Cholangiocarcinoma of the extrahepatic bile ducts. Semin Surg Oncol 19 (2000) 156-176
44. Patel A.H., Harnois D.M., Klee G.G., et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 95 (2000) 204-207
45. Chen C.Y., Shiesh S.C., Tsao H.C., and Lin X.Z. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma-the influence of sampling time and hepatolithiasis. Hepatogastroenterology 49 (2002) 616-620
46. Saini S. Imaging of the hepatobiliary tract. N Engl J Med 336 (1997) 1889-1894
47. Sharma M.P., and Ahuja V. Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: a clinician's perspective. Trop Gastroenterol 20 (1999) 167-169
48. Bloom C.M., Langer B., and Wilson S.R. Role of US in the detection, characterization, and staging of cholangiocarcinoma. Radiographics 19 (1999) 1199-1218
49. Bach A.M., Hann L.E., Brown K.T., et al. Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology 201 (1996) 149-154
50. Valls C., Gumà A., Puig I., et al. Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25 (2000) 490-496
51. Zhang Y., Uchida M., Abe T., et al. Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr 23 (1999) 670-677
52. Tillich M., Mischinger H.J., Preisegger K.H., et al. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. AJR Am J Roentgenol 171 (1998) 651-658
53. Asayama Y., Yoshimitsu K., Irie H., et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 238 (2006) 150-155
54. Han J.K., Choi B.I., Kim A.Y., et al. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics 22 (2002) 173-187
55. Feydy A., Vilgrain V., Denys A., et al. Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Am J Roentgenol 172 (1999) 73-77
56. Aloia T.A., Charnsangavej C., Faria S., et al. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg 193 (2007) 702-706
57. Xu A.M., Cheng H.Y., Jiang W.B., et al. Multi-slice three-dimensional spiral CT cholangiography: a new technique for diagnosis of biliary diseases. Hepatobiliary Pancreat Dis Int 1 (2002) 595-603
58. Ahmetoǧlu A., Koşucu P., Kul S., et al. MDCT cholangiography with volume rendering for the assessment of patients with biliary obstruction. AJR Am J Roentgenol 183 (2004) 1327-1332
59. Singh P., and Patel T. Advances in the diagnosis, evaluation and management of cholangiocarcinoma. Curr Opin Gastroenterol 22 (2006) 294-299
60. Romagnuolo J., Bardou M., Rahme E., et al. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med 139 (2003) 547-557
61. Guthrie J.A., Ward J., and Robinson P.J. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging. Radiology 201 (1996) 347-351
62. Schwartz L.H., Coakley F.V., Sun Y., et al. Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography. AJR. Am J Roentgenol 170 (1998) 1491-1495
63. Manfredi R., Brizi M.G., Masselli G., et al. [Malignant biliary hilar stenosis: MR cholangiography compared with direct cholangiography. Radiol Med (Torino) 102 (2001) 48-54
64. Rösch T., Meining A., Frühmorgen S., et al. A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 55 (2002) 870-876
65. Park M.S., Kim T.K., Kim K.W., et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 233 (2004) 234-240
66. Varghese J.C., Farrell M.A., Courtney G., et al. A prospective comparison of magnetic resonance cholangiopancreatography with endoscopic retrograde cholangiopancreatography in the evaluation of patients with suspected biliary tract disease. Clin Radiol 54 (1999) 513-520
67. Romagnuolo J., Bardou M., Rahme E., et al. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med 139 (2003) 547-557
68. Lee S.S., Kim M.H., Lee S.K., et al. MR cholangiography versus cholangioscopy for evaluation of longitudinal extension of hilar cholangiocarcinoma. Gastrointest Endosc 56 (2002) 25-32
69. Hänninen E.L., Pech M., Jonas S., et al. Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol 46 (2005) 462-470
70. Lee M.G., Park K.B., Shin Y.M., et al. Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography. World J Surg 27 (2003) 278-283
71. Pitt H.A., Nakeeb A., Abrams R.A., et al. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg 221 (1995) 788-797
72. Park M.S., Kim T.K., Kim K.W., et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 233 (2004) 234-240
73. Rösch T., Meining A., Frühmorgen S., et al. A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 55 (2002) 870-876
74. Kumar M., Prashad R., Kumar A., et al. Relative merits of ultrasonography, computed tomography and cholangiography in patients of surgical obstructive jaundice. Hepatogastroenterol 45 (1998) 2027-2032
75. Garrow D., Miller S., Sinha D., et al. Endoscopic ultrasound: a meta-analysis of test performance in suspected biliary obstruction. Clin Gastroenterol Hepatol 5 (2007) 616-623
76. Brugge W.R. Advances in the endoscopic management of patients with pancreatic and biliary malignancies. South Med J 99 (2006) 1358-1366
77. Lee J.H., Salem R., Aslanian H., et al. Endoscopic ultrasound and fine-needle aspiration of unexplained bile duct strictures. Am J Gastroenterol 99 (2004) 1069-1073
78. Fritscher-Ravens A., Broering D.C., Sriram P.V., et al. EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series. Gastrointest Endosc 52 (2000) 534-540
79. Chak A., and Catanzaro A. Innovative methods of biliary tract diagnosis: intraductal ultrasound and tissue acquisition. Gastrointest Endosc Clin N Am 13 (2003) 609-622
80. Farrell R.J., Agarwal B., Brandwein S.L., et al. Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures. Gastrointest Endosc 56 (2002) 681-687
81. Stavropoulos S., Larghi A., Verna E., et al. Intraductal ultrasound for the evaluation of patients with biliary strictures and no abdominal mass on computed tomography. Endoscopy 37 (2005) 715-721
82. Kapoor V., McCook B.M., and Torok F.S. An introduction to PET-CT imaging. Radiographics 24 (2004) 523-543
83. Wakabayashi H., Akamoto S., Yachida S., et al. Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture. Eur J Surg Oncol 31 (2005) 1175-1179
84. Anderson C.D., Rice M.H., Pinson C.W., et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8 (2004) 90-97
85. Kluge R., Schmidt F., Caca K., et al. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 33 (2001) 1029-1035
86. Petrowsky H., Wildbrett P., Husarik D.B., et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 45 (2006) 43-50
87. Fritscher-Ravens A., Bohuslavizki K.H., Broering D.C., et al. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 22 (2001) 1277-1285
88. Poneros J.M., Tearney G.J., Shiskov M., et al. Optical coherence tomography of the biliary tree during ERCP. Gastrointest Endosc 55 (2002) 84-88
89. Singh P., Chak A., Willis J.E., et al. In vivo optical coherence tomography imaging of the pancreatic and biliary ductal system. Gastrointest Endosc 62 (2005) 970-974
90. Singh P., and Patel T. Advances in the diagnosis, evaluation and management of cholangiocarcinoma. Curr Opin Gastroenterol 22 (2006) 294-299
91. Sakamoto E., Nimura Y., Hayakawa N., et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg 227 (1998) 405-411
92. Ebata T., Watanabe H., Ajioka Y., et al. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg 89 (2002) 1260-1267
93. Jarnagin W.R., Fong Y., DeMatteo R.P., et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234 (2001) 507-517
94. Nagorney D.M., and Kendrick M.L. Hepatic resection in the treatment of hilar cholangiocarcinoma. Adv Surg 40 (2006) 159-171
95. Seyama Y., and Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 13 (2007) 1505-1515
96. Kitagawa Y., Nagino M., Kamiya J., et al. Lymph node metastasis from hilar cholangiocarcinoma audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 233 (2001) 385-392
97. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). American Joint Committee on Cancer Staging. 6th ed. (2002), Springer-Verlag, New York
98. Jarnagin W.R., and Shoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis 24 (2004) 189-199
99. Anderson C.D., Pinson C.W., Berlin J., and Chari R.S. Diagnosis and treatment of cholangiocarcinoma. Oncologist 9 (2004) 43-57
100. Hemming A.W., Kim R.D., Mekeel K.L., et al. Portal vein resection for hilar cholangiocarcinoma. Am Surg 72 (2006) 599-604
101. Shimada H., Endo I., Sugita M., et al. Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder. World J Surg 27 (2003) 1137-1142
102. Corvera C.U., Weber S.M., and Jarnagin W.R. Role of laparoscopy in the evaluation of biliary tract cancer. Surg Oncol Clin N Am 11 (2002) 877-891
103. Goere D., Wagholikar G.D., Pessaux P., et al. Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc 20 (2006) 721-725
104. Weber S.M., DeMatteo R.P., Fong Y., et al. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg 235 (2002) 392-399
105. Connor S., Barron E., Wigmore S.J., et al. The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. J Gastrointest Surg 9 (2005) 476-480
106. Goere D., Wagholikar G.D., Pessaux P., et al. Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc 20 (2006) 721-725
107. Martin II R.C., Fong Y., DeMatteo R.P., et al. Peritoneal washings are not predictive of occult peritoneal disease in patients with hilar cholangiocarcinoma. J Am Coll Surg 193 (2001) 620-625
108. Sewnath M.E., Karsten T.M., Prins M.H., et al. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 236 (2002) 17-27
109. Aly E.A., and Johnson C.D. Preoperative biliary drainage before resection in obstructive jaundice. Dig Surg 18 (2001) 84-89
110. Nakeeb A., and Pitt H.A. The role of preoperative biliary decompression in obstructive jaundice. Hepatogastroenterology 42 (1995) 332-337
111. Seyama Y., and Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 13 (2007) 1505-1515
112. Kawasaki S., Imamura H., Kobayashi A., et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238 (2003) 84-92
113. Anderson C.D., Pinson C.W., Berlin J., and Chari R.S. Diagnosis and treatment of cholangiocarcinoma. Oncologist 9 (2004) 43-57
114. Nagino M., Kamiya J., Nishio H., et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243 (2006) 364-372
115. Abdalla E.K., Barnett C.C., Doherty D., et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 137 (2002) 675-680
116. Abdalla E.K., Hicks M.E., and Vauthey J.N. Portal vein embolization: rationale, technique and future prospects. Br J Surg 88 (2001) 165-175
117. Hemming A.W., Reed A.I., Howard R.J., et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237 (2003) 686-691
118. Shimada M., Yamashita Y., Aishima S., et al. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88 (2001) 1463-1466
119. Miwa S., Miyagawa S., Kobayashi A., et al. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 41 (2006) 893-900
120. Jan Y.Y., Yeh C.N., Yeh T.S., et al. Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma. World J Surg 29 (2005) 894-898
121. Ohtsuka M., Ito H., Kimura F., et al. Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10 (2003) 259-264
122. Uenishi T., Hirohashi K., Kubo S., et al. Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma. World J Surg 25 (2001) 865-869
123. Inoue K., Makuuchi M., Takayama T., et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 127 (2000) 498-505
124. Yamamoto M., Takasaki K., and Yoshikawa T. Extended resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6 (1999) 117-121
125. Madariaga J.R., Iwatsuki S., Todo S., et al. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 227 (1998) 70-79
126. Hanazaki K., Kajikawa S., Shimozawa N., et al. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology 49 (2002) 311-316
127. Hirohashi K., Uenishi T., Kubo S., et al. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 49 (2002) 326-329
128. Miwa S., Miyagawa S., Kobayashi A., et al. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 41 (2006) 893-900
129. Nimura Y., Hayakawa N., Kamiya J., et al. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 14 (1990) 535-543
130. Kitagawa Y., Nagino M., Kamiya J., et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 233 (2001) 385-392
131. Seyama Y., and Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 13 (2007) 1505-1515
132. Hasegawa S., Ikai I., Fujii H., et al. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg 31 (2007) 1256-1263
133. Dinant S., Gerhards M.F., Rauws E.A., et al. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol 13 (2006) 872-880
134. Rea D.J., Munoz-Juarez M., Farnell M.B., et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 139 (2004) 514-525
135. Kawasaki S., Imamura H., Kobayashi A., et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238 (2003) 84-92
136. Kawarada Y., Das B.C., Naganuma T., et al. Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies. J Gastrointest Surg 6 (2002) 617-624
137. Tabata M., Kawarada Y., Yokoi H., et al. Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 7 (2000) 148-154
138. Kosuge T., Yamamoto J., Shimada K., et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 230 (1999) 663-671
139. Miyazaki M., Ito H., Nakagawa K., et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?. Surgery 123 (1998) 131-136
140. Seiler C.A., Wagner M., Sadowski C., et al. Randomized prospective trial of pylorus-preserving vs. Classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg 4 (2000) 443-452
141. Riall T.S., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma-part 3: update on 5-year survival. J Gastrointest Surg 9 (2005) 1191-1204
142. Fong Y., Blungart L.H., Lin E., et al. Outcome of treatment for distal bile duct cancer. Br J Surg 83 (1996) 1712-1715
143. Wade T.P., Prasad C.N., Virgo K.S., and Johnson F.E. Experience with distal bile duct cancers in the US Veterans Affairs hospitals: 1987-1991. J Surg Oncol 64 (1997) 242-245
144. Murakami Y., Uemura K., Hayashidani Y., et al. Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis. World J Surg 31 (2007) 337-342
145. Yoshida T., Matsumoto T., Sasaki A., et al. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer. Arch Surg 137 (2002) 69-73
146. Meyer C.G., Penn I., and James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69 (2000) 1633-1637
147. Jeyarajah D.R., and Klintmalm G.B. Is liver transplantation indicated for cholangiocarcinoma?. J Hepatobiliary Pancreat Surg 5 (1998) 48-51
148. Pichlmayr R., Weimann A., Klempnauer J., et al. Surgical treatment in proximal bile duct cancer-a single-center experience. Ann Surg 224 (1996) 628-638
149. Sudan D., DeRoover A., Chinnakotla S., et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2 (2002) 774-779
150. Heimbach J.K., Gores G.J., Haddock M.G., et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 24 (2004) 201-207
151. Rea D.J., Heimbach J.K., Rosen C.B., et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242 (2005) 451-458
152. Todoroki T. Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology 47 (2000) 644-649
153. Thongprasert S. The role of chemotherapy in cholangiocarcinoma. Ann Oncol 16 (2005) 93-96
154. Gerhards M.F., van Gulik T.M., González González D., et al. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 27 (2003) 173-179
155. Sagawa N., Kondo S., Morikawa T., et al. Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma. Surg Today 35 (2005) 548-552
156. Stein D.E., Heron D.E., Rosato E.L., et al. Positive microscopic margins alter outcome in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy. Am J Clin Oncol 28 (2005) 21-23
157. Itoh H., Nishijima K., Kurosaka Y., et al. Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder. Dig Dis Sci 50 (2005) 2231-2242
158. Todoroki T., Ohara K., Kawamoto T., et al. Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys 46 (2000) 581-587
159. Hughes M.A., Frassica D.A., Yeo C.J., et al. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys 68 (2007) 178-182
160. McMasters K.M., Tuttle T.M., Leach S.D., et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 174 (1997) 605-608
161. Levy M.J., Baron T.H., Gostout C.J., et al. Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach. Clin Gastroenterol Hepatol 2 (2004) 273-285
162. Fumex F., Coumaros D., Napoleon B., et al. Similar performance but higher cholecystitis rate with covered biliary stents: results from a prospective multicenter evaluation. Endoscopy 38 (2006) 787-792
163. Park Do H., Kim M.H., Choi J.S., et al. Covered versus uncovered wallstent for malignant extrahepatic biliary obstruction: a cohort comparative analysis. Clin Gastroenterol Hepatol 4 (2006) 790-796
164. Davids P.H., Groen A.K., Rauws E.A., et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340 (1992) 1488-1492
165. Soderlund C., and Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 63 (2006) 986-995
166. Kaassis M., Boyer J., Dumas R., et al. Plastic or metal stents for malignant stricture of the common bile duct?. Results of a randomized prospective study. Gastrointest Endosc 57 (2003) 178-182
167. De Palma G.D., Galloro G., Siciliano S., et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc 53 (2001) 547-553
168. Sunpaweravong S., Ovartlarnporn B., Khow-ean U., et al. Endoscopic stenting versus surgical bypass in advanced malignant distal bile duct obstruction: cost-effectiveness analysis. Asian J Surg 28 (2005) 262-265
169. Prat F., Chapat O., Ducot B., et al. Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. Gut 42 (1998) 76-80
170. Smith A.C., Dowsett J.F., Russel R.C.G., et al. Randomized trial of endoscopic stenting versus surgical by-pass in malignant low bile duct obstruction. Lancet 344 (1994) 1655-1660
171. Shepherd H.A., Royle G., Ross A.P., et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 75 (1988) 1166-1168
172. Ohnishi H., Asada M., Shichijo Y., et al. External radiotherapy for biliary decompression of hilar cholangiocarcinoma. Hepatogastroenterology 42 (1995) 265-268
173. Cameron J.L., Pitt H.A., Zinner M.J., et al. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 159 (1990) 91-97
174. Bruha R., Petrtyl J., Kubecova M., et al. Intraluminal brachytherapy and self expandable stents in nonresectable biliary malignancies the question of long-term palliation. Hepatogastroenterology 48 (2001) 631-637
175. Choi C.W., Choi I.K., Seo J.H., et al. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas. Am J Clin Oncol 23 (2000) 425-428
176. Patt Y.Z., Jones Jr. D.V., Hoque A., et al. Phase II trial of intravenous fluorouracil and subcutaneous interferon alfa-2b for biliary tract cancer. J Clin Oncol 14 (1996) 2311-2315
177. Ducreux M., Rougier P., Fandi A., et al. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol 9 (1998) 653-656
178. Nehls O., Klump B., Arkenau H.T., et al. Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial. Br J Cancer 87 (2002) 702-704
179. Kubicka S., Rudolph K.L., Tietze M.K., et al. Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology 48 (2001) 783-789
180. Lee G.W., Kang J.H., Kim H.G., et al. Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma. Am J Clin Oncol 29 (2006) 127-131
181. Knox J.J., Hedley D., Oza A., et al. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol 23 (2005) 2332-2338
182. André T., Tournigand C., Rosmorduc O., et al. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol 15 (2004) 1339-1343
183. Eckel F., and Schmid R.M. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer 96 (2007) 896-902
184. Berr F., Wiedmann M., Tannapfel A., et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 31 (2000) 291-298
185. Ortner M.A. Photodynamic therapy in cholangiocarcinomas. Best Pract Res Clin Gastroenterol 18 (2004) 147-154
186. Ortner M.E., Caca K., Berr F., et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125 (2003) 1355-1363
187. Wiedmann M., Caca K., Berr F., et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer 97 (2003) 2783-2790
188. Zgodzinski W., and Espat N.J. Radiofrequency ablation for incidentally identified primary intrahepatic cholangiocarcinoma. World J Gastroenterol 11 (2005) 5239-5240
189. Burger I., Hong K., Schulick R., et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16 (2005) 353-361
190. Waggershauser T., Herrmann K., Schalhorn A., and Reiser M. Percutaneous implantation of port-catheter systems for intraarterial chemotherapy of the liver. Radiologe 39 (1999) 772-776
191. Sirica A.E. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 41 (2005) 5-15
192. Cheng Q., Luo X., Zhang B., et al. Distal bile duct carcinoma: prognostic factors after curative surgery. A Series 112. Ann Surg Oncal 14 (2007) 1212-1219